Stay updated with breaking news from Fredr Hirsch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC).
<p style="text-align:justify">Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of <em>non-small cell lung cancer (</em>NSCLC)<em>. </em> And in an early parallel study in humans, combining immunotherapy with dupilumab<em>—</em>an <a href="https://www.frontiersin.org/articles/10.3389/fimmu.2018.00888/full" target="_blank">Interleukin-4</a> (IL-4) receptor-blocking ant...
In this feature, we address 13 common myths and misconceptions regarding lung cancer. Among other topics, we cover smoking, pollution, and antioxidants.
There is virtually no chance of complete regression and only a 1% chance of any response for patients with advanced solid tumors who receive placebo in cancer drug trials.